KRAS and RASopathy: Mechanistically, the increased levels of activated KRAS-GTP and pERK detected in various biological samples including MEFs, heart tissue, or isolated blood platelets, appear to be the main driving force behind the various RASopathy-like phenotypes displayed by our HRAS/NRASDKO mice.